Sophie Château-Joubert Selected Research

indimitecan

1/2020

BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sophie Château-Joubert Research Topics

Disease

6	Neoplasms (Cancer) 01/2021 - 05/2013
6	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2016
5	Triple Negative Breast Neoplasms 01/2021 - 01/2018
3	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2018
2	Residual Neoplasm 01/2018 - 01/2016
1	Carcinogenesis 01/2021
1	Adenomyoepithelioma 01/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2020
1	Retinoblastoma (Glioblastoma, Retinal) 01/2020
1	Necrosis 05/2016

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2018
2	Phenobarbital (Luminal)FDA Link 01/2021 - 05/2016
2	palbociclibIBA 01/2020 - 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	methylamphotericin B (AME)IBA 01/2021
1	trametinibIBA 01/2021
1	dabrafenibIBA 01/2021
1	CateninsIBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	NSC 724998IBA 01/2020
1	indimitecanIBA 01/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2020
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2020
1	berzosertibIBA 01/2020
1	CamptothecinIBA 01/2020
1	Co-Repressor ProteinsIBA 01/2020
1	Topoisomerase I InhibitorsIBA 01/2020
1	Retinoblastoma ProteinIBA 01/2019
1	Matrix Metalloproteinase 17IBA 01/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	Messenger RNA (mRNA)IBA 05/2018
1	Tamoxifen FDA LinkGeneric 05/2018
1	Estrogens (Estrogen)FDA Link 05/2018
1	Capecitabine (Xeloda)FDA Link 01/2018
1	AnthracyclinesIBA 01/2018
1	Taxoids (Taxanes)IBA 01/2018
1	vandetanib (ZD6474)IBA 05/2016
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2016
1	Proto-Oncogene Proteins c-retIBA 05/2016
1	Phosphotransferases (Kinase)IBA 05/2016
1	Estrogen ReceptorsIBA 05/2016
1	Glutamine (L-Glutamine)FDA Link 05/2013
1	Glycoproteins (Glycoprotein)IBA 05/2013
1	LigandsIBA 05/2013
1	Glucose (Dextrose)FDA LinkGeneric 05/2013
1	Phosphates (Orthophosphate)IBA 05/2013
1	Pharmaceutical PreparationsIBA 05/2013

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2021 - 01/2016
2	Therapeutics 01/2021 - 01/2019
1	Neoadjuvant Therapy 01/2018